Register to receive a free U.S. Market Report Suite for Cardiac Surgery and Heart Valve Devices report synopsis and brochure
Medtronic, a global leader in percutaneous coronary intervention (PCI) innovation, revealed its launch of the Telescope™ Guide Extension Catheter, marking their entrance into the guide catheter market. This guide catheter is used to provide additional backup support and access to distal lesions, and to help deliver coronary stents, balloons and other interventional devices during angioplasty procedures that help with blood flow through the coronary and peripheral arteries.
Medtronic’s Telescope™ guide extension catheter integrates a solid, round pushwire with a coil-reinforced hydrophilic-coated distal segment to help medical practitioners reach challenging lesions with improved pushability and range of motion. Telescope™ utilizes a flexible TruFlex™ soft polymer tip, which is designed to responsively bend and deflect during use. When the Telescope™ is in position near the target area, SmoothPass technology helps to effortlessly maneuver stents, balloons, and other interventional devices into place.
“It is not an exaggeration to say that guide extension technologies have greatly impacted the ability to deliver devices to the distal coronary vasculature, especially for cases where traditional guide support may be limited,” said Ajay Kirtane, M.D., S.M., director of the New York-Presbyterian Hospital/Columbia University Cardiac Catheterization Laboratories. “In this light, the Telescope – a guide extension catheter with specific design optimizations aiming to stably deliver devices through tortuous anatomy – is a welcome addition to the interventional toolbox.”
According to iData Research, the cardiac surgery market is valued at over $5.1 billion, and is forecasted to grow to $10 billion by 2024. Cardiac surgery is a rapidly growing market with new technological innovations occurring constantly. As such, new segments arise and foster growth, such as the remote hemodynamic monitoring segment. The largest segment of the cardiac surgery market would be the transcatheter heart valve replacement (THVR) market, which is a rapidly growing segment and is projected to maintain its dominance in this market. The expansive growth comes from the minimally invasive procedure trend, allowing it to over populate the surgical heart valve market’s procedure numbers. The Telescope™ device is estimated to be one of the driving forces to grow the cardiac surgery segment.
“Before bringing this important technology to market, we collaborated with more than 700 interventional cardiologists to ensure Telescope™ was addressing unmet needs in complex PCI,” said Dave Moeller, vice president and general manager of the Coronary and Renal Denervation business, which is part of the Cardiac and Vascular Group at Medtronic. “We will continue to make investments in cutting edge interventional technologies, clinical evidence expansion, and robust physician training programs, which we believe will make a meaningful difference for physicians and their patients.”
For Further Information
More on the cardiac surgery and heart valve market can be found in a series of reports published by iData entitled the U.S. Market Report Suite for Cardiac Surgery and Heart Valve Devices.